NET PROFIT (x1000 NOK)
EMPLOYEES
Signum Life Science ApS
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
-4,303
|
-18,973
|
3,738 |
| Total assets |
198,261
|
188,962
|
202,480 |
| Current assets |
80,356
|
78,717
|
92,544 |
| Current liabilities |
20,233
|
17,224
|
20,429 |
| Equity capital |
170,049
|
163,965
|
172,293 |
| - share capital |
113
|
106
|
101 |
| Employees (average) |
35
|
35
|
35 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
85.8%
|
86.8%
|
85.1% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
397.2%
|
457.0%
|
453.0% |
| Return on equity (ROE) |
-2.5%
|
-11.6%
|
2.2% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.